Category: Health & Medicines > Health Care Supplement
Country/Region: India State/Province: Delhi
Main Products: Diminazene Diaceturate, Diminazene Granules, Quinapyramine Sulphate And Chloride, Toldimphos, Bithionol Sulfoxide, Roxarzone, Sildenafil Citrate, Nalidixic, Allantoin
Business Type: Manufacturer, Retailer
Year Established: 1997
Employees: 11 - 50 People
Plant Area: 3,000-5,000 square meters
Main Markets: South America 10% Africa 12% Eastern Asia 11% Domestic Market 11% North America 12% Eastern Europe 9% Southern Europe 12% Mid East 8% Northern Europe 10% Oceania 5%
Trade Capacity: FOB, CIF, DDP
Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered
Nearest Port: India
Annual Revenue: Below US$1 Million
Total Revenue: US$50 Million - US$100 Million
Export Revenue: Above US$100 Million
Annual Output: Below US$1 Million
Registered Capital: US$50 Million - US$100 Million
Export Percentage: 51% - 60%
Payment Modes: USD, JPY, CNY
Lead Time: 7 days
Import/Export Mode: Using an agent